We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Whitehead Institute For Biomedical Research is a company based in Cambridge, Ma that has hired a total of 3 Perm Visa Employees as of across 1 locations, with the majority of hires in MA.

The primary jobs hired include Statisticians, Biological Technicians, and Biological Scientists, All Other.

The average salary at Whitehead Institute For Biomedical Research for the jobs listed above is $48,469.50.

This company has mostly hired people from the Scientific Research and Development Services industry

The company has been hiring employees since at least 2010, and the number of Perm employees has remained relatively consistent , while the average salary has been decreasing over time.

Whitehead Institute For Biomedical Research has a Perm Visa approval rate of 50.00% .


Employer Summary

Whitehead Institute For Biomedical Research
Nine Cambridge Center
Cambridge, MA

Total Applications

6

Average Wage

$45,957.83

Visa Status

3 Approved

0 Denied

0 Withdrawn

3 Certified Expired

Whitehead Institute For Biomedical Research Top Perm Visa Jobs


Job Title Job Location Salary Number Of Jobs
Statisticians Cambridge, Ma $52,354.00 1
Biological Technicians Cambridge, Ma $45,573.00 1
Biological Scientists, All Other Cambridge, Ma $50,378.00 1

Whitehead Institute For Biomedical Research Employees Over Time vs Average Salary Over Time

Whitehead Institute For Biomedical Research has been in the Perm Visa program since 2010 where they hired 3 employees. They peaked in 2010 with 3 employees, and the recent trend shows the average number of employees on an incline.

Whitehead Institute For Biomedical Research has been in the Perm Visa program since 2010 where the average salary was $48,470. They peaked in 2010 with an average salary of $48,470, and have since been on a decline with the most recent average salary being $34,632 in 2023.